39-Week nulliparous inductions are not  elective

In August 2018, Grobman et  al1 published findings from the ARRIVE Trial: A Randomized Trial of Induction vs Expectant Management. More than 6000 women underwent random assignment at 41 academic and community hospitals that were participating in the Maternal-Fetal Medicine Units Network; 3062 women were assigned to labor ind uction, and 3044 women were assigned to expectant treatment. There was no difference in the primary outcome, which was a composite of adverse perinatal outcomes. Women who underwent labor induction were significantly less likely to deliver by cesarean (18.6 % vs 22.2%; relative risk, 0.84; 95% confi dence interval, 0.76–0.93) and were less likely to experience hypertensive disorders of pregnancy (9.1% vs 14.1%; relative risk, 0.64; 95% confidence interval, 0.56–0.74).
Source: American Journal of Obstetrics and Gynecology - Category: OBGYN Authors: Tags: Editorial Source Type: research